Unlock stock picks and a broker-level newsfeed that powers Wall Street.

LSE - Delayed Quote GBp

Spire Healthcare Group plc (SPI.L)

Compare
188.00
+4.60
+(2.51%)
At close: April 15 at 4:44:22 PM GMT+1

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
NameTitlePayExercisedYear Born
Mr. Justinian Joseph Ash BA (Hons) CEO & Executive Director 1.07M -- 1965
Mr. Harbant Singh Samra CFO & Director 541.08k -- 1979
Mr. John Forrest Chief Operating Officer -- -- --
Mr. Angus Prentice Interim Head of Investor Relations -- -- --
Mr. Mantraraj Dipak Budhdev Group General Counsel, Company Secretary & Corporate Concerns Director -- -- 1986
Ms. Rachel King Group People Director -- -- --
Mr. Peter Corfield Chief Commercial Officer -- -- --
Prof. Lisa Jane Grant Group Clinical Director & Chief Nurse -- -- 1976
Mr. Derrick Michael Farrell Chief Executive Officer of Vita Health Group -- -- --

Spire Healthcare Group plc

3 Dorset Rise
London, EC4Y 8EN
United Kingdom
44 20 7427 9000 https://www.spirehealthcare.com
Sector: 
Healthcare
Full Time Employees: 
15,703

Description

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. The company operates in three segments: Hospitals Business, Vita Health Group, and The Doctors Clinic Group. It provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. The company also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, it provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. Further, the company offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal surgery and treatments, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, it provides treatments in the areas of back surgery, breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

Corporate Governance

Spire Healthcare Group plc’s ISS Governance QualityScore as of April 1, 2025 is 4. The pillar scores are Audit: 5; Board: 6; Shareholder Rights: 1; Compensation: 4.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 6, 2025 at 7:00 AM UTC

Spire Healthcare Group plc Earnings Date

May 22, 2025 at 12:00 AM UTC

Ex-Dividend Date

Recent Events

Related Tickers